OCCL Q3 FY26 Share Price & Earnings Call Analysis
- Market cap
- ₹873 Cr
- P/E
- 11.44
- ROE
- 12.15%
- PEG
- 0.01
- Price to sales
- 1.46
- Debt to equity
- 0.21
- 52W high / low
- ₹233 / ₹77.8
- EBITDA margin
- 20.66%
- Net profit margin
- 9.94%
- Promoter holding
- 51.76%
- Sales (last year)
- ₹602 Cr
Guidance scorecard · Q3 FY26 call
What OCCL's management guided
and where it ranks in Chemicals & Petrochemicals
RevenueQ3 FY26 call
0–10%- Volumes have been stable recently with no significant increase expected in the next quarter.
- Capacity utilization is currently around 70%, with some expected increase in FY'27, though exact levels will be clearer by May-June 2026.
- The company prioritizes capturing market share in exports despite global oversupply and weak international pricing.
- Domestic market share growth is a strategic focus, leveraging anti-dumping duties and favorable market conditions.
- Export market strategy, especially in the US and Europe, is expected to regain momentum following tariff reductions and discount normalization.
2 more points from OCCL's call on revenue
Create a free account to keep reading this call
MarginsQ3 FY26 call
FlatSee what OCCL said on margins — free account, 30 seconds.
CapexQ3 FY26 call
- Current capacity utilization is around 70%.
- Some increase in capacity utilization is expected in FY'27, but exact figures will be clearer by May-June 2026.
- Strategies focus on volume retention, market share capture, and margin protection.
- The company is focusing on increasing domestic market share and rejuvenating export markets as tariffs ease.
FundraisingQ3 FY26 call
See what OCCL said on fundraising — free account, 30 seconds.
Order bookQ3 FY26 call
Ask what OCCL said on the order book →
Full Q3 FY26 analysisRanges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Chemicals & Petrochemicals companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 0–2% | ₹263 Cr | 3.4 | |
| 2 | 40%+ | Flat | ₹4,375 Cr | 83.7 | |
| 3 | 40%+ | Flat | ₹3,259 Cr | 4.0 | |
| 4 | 40%+ | Flat | ₹145 Cr | 15.9 | |
| 5 | 20–40% | Up 2%+ | ₹1.81L Cr | 90.9 | |
| 6 | 20–40% | Up 2%+ | ₹48,366 Cr | 78.3 |
Sign up free to see every company in the sector ranking and track OCCL.
Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals rankingFinancials of OCCL
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of OCCL
Quarterly Results
Quarter-by-quarter operating performance
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 0 | 0 | 0 | 0 | 103 | 96 | 107 | 123 | 120 | 114 | 149 |
| Expenses + | 0 | 0 | 0 | 0 | 85 | 80 | 89 | 97 | 100 | 94 | 125 |
| Operating Profit | -0 | -0 | -0 | -0 | 19 | 16 | 19 | 26 | 19 | 20 | 24 |
| OPM % | 18% | 16% | 17% | 21% | 16% | 17% | 16% | ||||
| Other Income + | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | -3 | 2 |
| Interest | 0 | 0 | 0 | 0 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Profit before tax | -0 | -0 | -0 | -0 | 10 | 7 | 11 | 18 | 12 | 8 | 17 |
| Tax % | 0% | 0% | -20% | 100% | 26% | 26% | 24% | 28% | 25% | 23% | -13% |
| Net Profit + | 0 | 0 | -0 | -0 | 8 | 5 | 9 | 13 | 9 | 7 | 19 |
| EPS in Rs | 1.50 | 1.05 | 1.74 | 2.63 | 1.74 | 1.31 | 3.87 |
Financials of OCCL
Profit & Loss
Annual income statement trend
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales + | 0 | 0 | 307 | 506 |
| Expenses + | 0 | 0 | 254 | 417 |
| Operating Profit | -0 | -0 | 53 | 89 |
| OPM % | 17% | 18% | ||
| Other Income + | 0 | 0 | 2 | 0 |
| Interest | 0 | 0 | 5 | 5 |
| Depreciation | 0 | 0 | 21 | 29 |
| Profit before tax | -0 | -0 | 29 | 55 |
| Tax % | -33% | -14% | 25% | 14% |
| Net Profit + | -0 | -0 | 21 | 48 |
| EPS in Rs | 4.29 | 9.55 | ||
| Dividend Payout % | 0% | 0% | 35% | 19% |
Financials of OCCL
Balance Sheet
Capital structure and asset base
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 10 | 10 |
| Reserves | -0 | -0 | 386 | 421 |
| Borrowings + | 0 | 0 | 62 | 84 |
| Other Liabilities + | 0 | 0 | 76 | 86 |
| Total Liabilities | 0 | 0 | 534 | 602 |
| Fixed Assets + | 0 | 0 | 379 | 363 |
| CWIP | 0 | 0 | 3 | 2 |
| Investments | 0 | 0 | 11 | 14 |
| Other Assets + | 0 | 0 | 141 | 222 |
| Total Assets | 0 | 0 | 534 | 602 |
Financials of OCCL
Cash Flows
Operating, investing and financing cash movement
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from Operating Activity + | -0 | 70 | 11 | |
| Cash from Investing Activity + | 0 | 4 | -17 | |
| Cash from Financing Activity + | 0 | -74 | 10 | |
| Net Cash Flow | 0 | 0 | 4 | |
| Free Cash Flow | -0 | 57 | -4 | |
| CFO/OP | 133% | 140% | 22% |
Financials of OCCL
Ratios
Working capital efficiency and return ratios
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 77 | 61 | ||
| Inventory Days | 188 | 139 | ||
| Days Payable | 77 | 41 | ||
| Cash Conversion Cycle | 189 | 160 | ||
| Working Capital Days | 67 | 69 | ||
| ROCE % | -86% | 15% | 13% |
Guidance history
How OCCL's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q3 FY26 call → | 0–10% | Flat | — | — | — |
| Q2 FY26 call → | 10–20% | Flat | — | — | — |
| Q1 FY26 call → | 10–20% | Flat | None planned | — | — |
| Q4 FY25 call → | 0–10% | Flat | None planned | — | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
42 out of 100 — Steady
Over the past year its share price has moved roughly in the middle of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | +27.8% | 77% |
| Last 6 months | +75.9% | 94% |
| Last 3 months | +10.6% | 80% |
The price is 24.9% below its all-time high of ₹232.91 (12 Oct 2026). Stocks more than 20% below their peak have their score halved, so 84 became 42.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For OCCL: 0.4 × 77 + 0.4 × 94 + 0.2 × 80 = 84, halved to 42 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What OCCL's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
- Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks
- NOCIL Ltd (Q2 FY27)
427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.